Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 20.53% is 11% below its 5-year average of 23.13%, near the low end of its 5-year range (18.27%–29.02%).
As of the fiscal period ended Tuesday, June 30, 2026. 0.51% below its 12-month average of 20.64%.
Reported quarterly operating margin; no daily interpolation.
OPERATING MARGIN
20.53%
OPERATING MARGIN AVG TTM
20.64%
OPERATING MARGIN AVG 3Y
21.34%
OPERATING MARGIN AVG 5Y
23.13%
OPERATING MARGIN AVG 10Y
19.80%
OPERATING MARGIN AVG 15Y
17.10%
OPERATING MARGIN AVG 20Y
15.06%
CURRENT VS TTM AVG
-0.51%
CURRENT VS 3Y AVG
-3.79%
CURRENT VS 5Y AVG
-11.24%
CURRENT VS 10Y AVG
+3.70%
CURRENT VS 15Y AVG
+20.08%
CURRENT VS 20Y AVG
+36.35%
SECTOR MEDIAN · HEALTHCARE
15.61%
median of 76 covered companies
CURRENT VS SECTOR MEDIAN
+31.57%
vs the sector median at left
West Pharmaceutical Services, Inc.
Market Cap
$24.46B
Operating Margin
20.53%
TTM Avg
20.64%
3Y Avg
21.34%
5Y Avg
23.13%
Market Cap
$24.36B
Operating Margin
31.57%
TTM Avg
14.26%
3Y Avg
15.92%
5Y Avg
12.23%
Market Cap
$25.16B
Operating Margin
-158.13%
TTM Avg
-140.72%
3Y Avg
-73.36%
5Y Avg
-52.24%
Market Cap
$26.11B
Operating Margin
14.14%
TTM Avg
14.08%
3Y Avg
14.06%
5Y Avg
16.54%
Market Cap
$26.45B
Operating Margin
11.27%
TTM Avg
9.61%
3Y Avg
9.32%
5Y Avg
13.00%
Market Cap
$21.33B
Operating Margin
44.49%
TTM Avg
47.77%
3Y Avg
49.26%
5Y Avg
45.01%
Market Cap
$28.73B
Operating Margin
28.69%
TTM Avg
28.45%
3Y Avg
28.53%
5Y Avg
27.71%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| West Pharmaceutical Services, Inc. (WST) | $24.46B | 20.53% | 20.64% | 21.34% | 23.13% |
| Incyte Corporation (INCY)vs › | $24.36B | 31.57% | 14.26% | 15.92% | 12.23% |
| Moderna, Inc. (MRNA)vs › | $25.16B | -158.13% | -140.72% | -73.36% | -52.24% |
| BioNTech SE (BNTX)vs › | $23.30B | -22.63% | -35.20% | 5.18% | 14.03% |
| STERIS plc (STE)vs › | $22.84B | 18.91% | 17.21% | 17.04% | 16.18% |
| Quest Diagnostics Incorporated (DGX)vs › | $26.11B | 14.14% | 14.08% | 14.06% | 16.54% |
| Labcorp Holdings Inc. (LH)vs › | $26.45B | 11.27% | 9.61% | 9.32% | 13.00% |
| United Therapeutics Corporation (UTHR)vs › | $21.33B | 44.49% | 47.77% | 49.26% | 45.01% |
| Mettler-Toledo International Inc. (MTD)vs › | $28.73B | 28.69% | 28.45% | 28.53% | 27.71% |
| Zimmer Biomet Holdings, Inc. (ZBH)vs › | $18.95B | 15.73% | 16.64% | 15.15% | 12.43% |
Gross Margin
36.8%
Operating Margin
20.5%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 20.53% |
| 2026-03-31 | 20.96% |
| 2025-12-31 | 19.45% |
| 2025-09-30 | 21.60% |
| 2025-06-30 | 20.65% |
| 2025-03-31 | 18.39% |
| 2024-12-31 | 22.79% |
| 2024-09-30 | 22.47% |
| 2024-06-30 | 18.63% |
| 2024-03-31 | 18.27% |
| 2023-12-31 | 23.30% |
| 2023-09-30 | 25.57% |
| 2023-06-30 | 24.83% |
| 2023-03-31 | 23.40% |
| 2022-12-31 | 22.84% |
| 2022-09-30 | 27.33% |
| 2022-06-30 | 29.02% |
| 2022-03-31 | 25.96% |
| 2021-12-31 | 24.81% |
| 2021-09-30 | 25.97% |
| 2021-06-30 | 28.99% |
| 2021-03-31 | 26.87% |
| 2020-12-31 | 21.08% |
| 2020-09-30 | 19.46% |
| 2020-06-30 | 20.54% |
| 2020-03-31 | 17.20% |
| 2019-12-31 | 16.50% |
| 2019-09-30 | 16.06% |
| 2019-06-30 | 16.53% |
| 2019-03-31 | 15.36% |
| 2018-12-31 | 20.60% |
| 2018-09-30 | 12.53% |
| 2018-06-30 | 12.19% |
| 2018-03-31 | 11.80% |
| 2017-12-31 | 14.45% |
| 2017-09-30 | 11.34% |
| 2017-06-30 | 13.57% |
| 2017-03-31 | 15.88% |
| 2016-12-31 | 14.13% |
| 2016-09-30 | 14.12% |
| 2016-06-30 | 15.77% |
| 2016-03-31 | 8.29% |
| 2015-12-31 | 12.57% |
| 2015-09-30 | -1.02% |
| 2015-06-30 | 10.87% |
| 2015-03-31 | 14.23% |
| 2014-12-31 | 12.75% |
| 2014-09-30 | 12.36% |
| 2014-06-30 | 14.67% |
| 2014-03-31 | 11.33% |
| 2013-12-31 | 10.77% |
| 2013-09-30 | 11.61% |
| 2013-06-30 | 12.34% |
| 2013-03-31 | 12.76% |
| 2012-12-31 | 9.80% |
| 2012-09-30 | 8.66% |
| 2012-06-30 | 10.96% |
| 2012-03-31 | 13.18% |
| 2011-12-31 | 9.14% |
| 2011-09-30 | 8.89% |
| 2011-06-30 | 9.03% |
| 2011-03-31 | 9.75% |
| 2010-12-31 | 2.13% |
| 2010-09-30 | 9.32% |
| 2010-06-30 | 10.82% |
| 2010-03-31 | 10.52% |
| 2009-12-31 | 7.40% |
| 2009-09-30 | 10.00% |
| 2009-06-30 | 10.96% |
| 2009-03-31 | 8.75% |
| 2008-12-31 | 10.46% |
| 2008-09-30 | 6.99% |
| 2008-08-05 | 15.25% |
| 2008-03-31 | 14.07% |
| 2007-12-31 | 2.97% |
| 2007-09-30 | 5.32% |
| 2007-06-30 | 13.23% |
| 2007-03-31 | 15.37% |
| 2006-12-31 | 9.06% |
| 2006-09-30 | 9.02% |
| 2006-06-30 | 13.36% |
| 2006-03-31 | 12.66% |
| 2005-12-31 | 9.71% |
| 2005-09-30 | 7.27% |
| 2005-06-30 | 11.50% |
| 2005-03-31 | 13.44% |
| 2004-12-31 | 14.41% |
| 2004-09-30 | 4.73% |
| 2004-06-30 | 8.40% |
| 2004-03-31 | 8.08% |
| 2003-12-31 | 23.97% |
| 2003-09-30 | 5.75% |
| 2003-06-30 | 8.54% |
| 2003-03-31 | 5.52% |
| 2002-12-31 | 6.67% |
| 2002-09-30 | -2.57% |
